Inovio Pharmaceuticals, Inc. SEC filings INO
Inovio Pharmaceuticals, Inc. has 1,004 filings in SEC EDGAR's recent list, going back to Feb 20, 2008. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| FWP | Free writing prospectus | Nov 6, 2026 | — |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 424B5 | Prospectus supplement | Nov 5, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 2, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 31, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 31, 2026 | Jul 29, 2026 |
| 424B5 | Prospectus supplement | Jul 30, 2026 | — |
| 8-K |
Current report
Results of operations
|
Jul 29, 2026 | Jul 29, 2026 |
| 424B5 | Prospectus supplement | Jul 29, 2026 | — |
| EFFECT | Filing | Jul 10, 2026 | — |
| S-3 | Shelf registration | Jul 2, 2026 | — |
| S-8 | Employee stock plan registration | May 26, 2026 | — |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 20, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 15, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 6, 2026 | — |
| DEF 14A | Proxy statement | Apr 7, 2026 | May 20, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 6, 2026 | Apr 2, 2026 |
| 424B5 | Prospectus supplement | Apr 2, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 2, 2026 | Apr 1, 2026 |
| 424B5 | Prospectus supplement | Apr 2, 2026 | — |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 30, 2026 | — |
| 424B5 | Prospectus supplement | Jan 27, 2026 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Jan 27, 2026 | Jan 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 29, 2025 | Dec 29, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 8, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 5, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 13, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Nov 12, 2025 | Nov 11, 2025 |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 17, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 7, 2025 | Jul 2, 2025 |
| 424B5 | Prospectus supplement | Jul 3, 2025 | — |
| 424B5 | Prospectus supplement | Jul 2, 2025 | — |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | May 12, 2025 | May 10, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 30, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 17, 2025 | — |
| ARS | Annual report to shareholders | Apr 7, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 7, 2025 | May 20, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2025 | Mar 18, 2025 |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 10, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 30, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 23, 2024 | — |
| 4 | Insider transaction | Dec 18, 2024 | Dec 18, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 16, 2024 | Dec 12, 2024 |
| 424B5 | Prospectus supplement | Dec 13, 2024 | — |
| 424B5 | Prospectus supplement | Dec 12, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| 424B5 | Prospectus supplement | Aug 13, 2024 | — |
| 8-K |
Current report
Material agreement
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jul 1, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 28, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 15, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 13, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 10, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| SC 13G | Ownership over 5% (passive) | Apr 26, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Apr 17, 2024 | Apr 15, 2024 |
| 424B5 | Prospectus supplement | Apr 17, 2024 | — |
| ARS | Annual report to shareholders | Apr 15, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 11, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 6, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 28, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| EFFECT | Filing | Jan 31, 2024 | — |
| CORRESP | Letter to the SEC | Jan 29, 2024 | — |
| S-3/A | Filing | Jan 26, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 25, 2024 | Jan 24, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 22, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jan 12, 2024 | Jan 12, 2024 |
| DEF 14A | Proxy statement | Nov 28, 2023 | Jan 12, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 17, 2023 | Jan 12, 2024 |
| UPLOAD | Letter from the SEC | Nov 16, 2023 | — |
| S-3 | Shelf registration | Nov 9, 2023 | — |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 2, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 10, 2023 | Oct 10, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Exit or restructuring costs
|
Aug 1, 2023 | Jul 31, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 10, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 7, 2023 | — |
| 4 | Insider transaction | Jul 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 23, 2023 | Jun 23, 2023 |
| 4 | Insider transaction | Jun 5, 2023 | Jun 5, 2023 |
| 144 | Notice of proposed sale | Jun 5, 2023 | — |
| S-8 | Employee stock plan registration | May 18, 2023 | — |
| S-8 | Employee stock plan registration | May 18, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 18, 2023 | May 16, 2023 |
| 4 | Insider transaction | May 17, 2023 | May 15, 2023 |
| 4 | Insider transaction | May 17, 2023 | May 15, 2023 |
| 4 | Insider transaction | May 17, 2023 | May 15, 2023 |
| 4 | Insider transaction | May 17, 2023 | May 15, 2023 |
| 4 | Insider transaction | May 16, 2023 | May 15, 2023 |
| 4 | Insider transaction | May 16, 2023 | May 15, 2023 |
| 4 | Insider transaction | May 16, 2023 | May 15, 2023 |
| 4 | Insider transaction | May 16, 2023 | May 15, 2023 |
| 4 | Insider transaction | May 16, 2023 | May 15, 2023 |
| 4 | Insider transaction | May 16, 2023 | May 15, 2023 |
| 4 | Insider transaction | May 16, 2023 | May 13, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Plymouth Meeting, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1055726
- Former names
- INOVIO BIOMEDICAL CORP (until May 11, 2010); GENETRONICS BIOMEDICAL CORP (until Apr 1, 2005); GENETRONICS BIOMEDICAL LTD (until Aug 3, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.